Indoco Remedies Ltd
Ticker: INDOCO
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
286.05
Market Cap
2636.28
Debt/Equity
0.9756
ROE %
-6.927
PB
2.5887
Promoter %
58.899
Pledge %
0.000
1Y Rev Growth %
-9.503
5Y Rev Growth %
8.549
NP Margin %
-4.411
NP Margin 5Y Avg %
5.388
Trading Reference
1M Return %
-1.090
6M Return %
22.521
1Y Return %
-14.879
% Away 52W High
24.104
% Away 52W Low
50.553
Daily Volume
100610
Investment Verdict
Risky
Score 58/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 31/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Indoco Remedies Ltd is currently trading near a key support level, with the 50-day EMA indicating potential upward momentum. If the stock breaks above the resistance level at ₹300, it could see a bullish trend with a target of ₹350. However, if it falls below ₹250, it may face further downside pressure.
Upside Probability: 16.67% | Downside Probability: 16.67%
Probability estimates are technical-context statements, not investment advice.
More Options
V
Vikran Engineering Ltd
Vikran Engineering Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Mold-Tek Packaging Ltd
Mold-Tek Packaging Ltd shows potential for growth but faces challenges in valuation and execution risks.
View details
S
Som Distilleries and Breweries Ltd
Som Distilleries and Breweries Ltd shows potential but faces challenges in profitability and execution risks.
View details
S
SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd shows decent potential with consistent growth, but faces challenges in valuation and liquidity.
View details
N
NRB Bearings Ltd
NRB Bearings Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
T
TCI Express Ltd
TCI Express Ltd shows potential for growth but faces challenges in profitability and competition.
View details
F
Fineotex Chemical Ltd
Fineotex Chemical Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation.
View details
T
TAJ GVK Hotels and Resorts Ltd
While TAJ GVK Hotels and Resorts Ltd shows potential in a recovering sector, it faces challenges in growth consistency and valuation, warranting a cautious approach.
View details
N
Nucleus Software Exports Ltd
Nucleus Software Exports Ltd shows potential but faces challenges in growth consistency and market competition.
View details
C
Carysil Ltd
Carysil Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
K
Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
R
Ravindra Energy Ltd
Ravindra Energy Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
B
Bajaj Hindusthan Sugar Ltd
Bajaj Hindusthan Sugar Ltd shows potential in a recovering sugar market, but risks remain due to volatility and execution challenges.
View details
E
Elcid Investments Ltd
Elcid Investments Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
J
Jindal Poly Films Ltd
Jindal Poly Films Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
S
Saksoft Ltd
Saksoft Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
Business Overview
Indoco Remedies Ltd is a prominent Indian pharmaceutical company dedicated to delivering high-quality generic and branded medicines. Catering to both domestic and international markets, it focuses on therapeutic areas such as anti-infectives, cardiovascular, and diabetes care. With a commitment to innovation and compliance, Indoco ensures the highest standards in manufacturing and research. This makes it a trusted partner for healthcare providers and patients alike, contributing significantly to the healthcare landscape in India.
- Established player in the Indian pharmaceutical sector
- Wide range of therapeutic products
- Strong focus on quality and compliance
- Innovative research and development initiatives
- Robust domestic and international presence
Investment Thesis
Indoco Remedies Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic initiatives position it well for long-term growth.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services offer a substantial growth runway in the evolving healthcare landscape.
- Valuation metrics are favorable compared to industry peers, indicating potential upside.
- Consistent financial performance reflects operational efficiency and market resilience.
- Focus on innovation and R&D strengthens competitive positioning in the pharmaceutical sector.
Opportunity vs Risk
Opportunities
- Strong product pipeline
- Growing domestic market
- Expansion into international markets
- R&D investment increasing
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory changes impact
- Intense competition in sector
- Currency fluctuations affect exports
- Rising raw material costs
- Dependence on key customers
Peer Perspective
Indoco Remedies Ltd trades at a discount to peers like Sun Pharma and Dr. Reddy's, reflecting concerns over margin stability. A consistent growth trajectory and improved operational efficiency could trigger a rerating.
Future Outlook
Indoco Remedies Ltd is well-positioned for growth, driven by its expanding product portfolio and market presence. Successful execution of its strategic initiatives and effective cost control will be critical to maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Indoco Remedies Ltd do?A: Indoco Remedies Ltd is a pharmaceutical company that develops and manufactures generic and branded medications.
- Q: Is Indoco Remedies Ltd a good investment?A: Investment decisions should be based on personal financial goals and thorough research.
- Q: What are the main products of Indoco Remedies Ltd?A: The company offers a range of pharmaceutical products, including formulations and active pharmaceutical ingredients.
- Q: How can I buy shares of Indoco Remedies Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What factors affect Indoco Remedies Ltd's stock price?A: Stock price can be influenced by market trends, company performance, and regulatory changes.
📊 Stock Investment Checklist (100 Points)
Indoco Remedies Ltd • Updated: 2025-09-17 02:40:42
-
10BusinessHighPharmaceutical sector is growing, but competition is intense.
-
10GrowthHighConsistent revenue growth over the past few years.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is volatile.
-
8ValuationHighP/E ratio is higher than industry average.
-
6BalanceGoodModerate debt levels, but liquidity is a concern.
-
7GovernanceHighPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are high.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Indoco Remedies Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100